Related Experiment Video
Updated: Jun 26, 2026

Integration of Miniaturized Solid Phase Extraction and LC-MS/MS Detection of 3-Nitrotyrosine in Human Urine for Clinical Applications
Published on: July 14, 2017
Box-Behnken Design-Based Development and Validation of RP-HPLC Method for Determination of Related Substances in
Prasanth Katakam1, Mahesh J Wadgeri2, Bharat Kumar Tripuramallu1
1Department of Chemistry, Vignan's Foundation for Science Technology & Research, Guntur, Andhra Pradesh, India.
A new stable reversed-phase high-performance liquid chromatography (RP-HPLC) method, optimized using Box-Behnken design, accurately quantifies impurities in nitrofurantoin capsules. This validated method ensures quality control and addresses safety concerns regarding degradation products.
Area of Science:
- Analytical Chemistry
- Pharmaceutical Analysis
Background:
- Nitrofurantoin is an antibiotic susceptible to degradation.
- Ensuring the quality and safety of nitrofurantoin formulations requires accurate quantification of related substances and impurities.
- Existing analytical methods may not fully address the stability-indicating requirements for nitrofurantoin.
Purpose of the Study:
- To develop and validate a stable reversed-phase high-performance liquid chromatography (RP-HPLC) method for quantifying related substances in nitrofurantoin capsule formulations.
- To optimize the RP-HPLC method using Box-Behnken design for improved performance and dependability.
- To provide a robust analytical approach for routine quality control and regulatory compliance.
Main Methods:
- Development of a gradient elution RP-HPLC method using specific mobile phase compositions (formic acid/tetrahydrofuran and methanol/acetonitrile/tetrahydrofuran).
- Utilized Box-Behnken design, a response surface methodology, for systematic optimization of method parameters.
- Employed an Inertsil ODS-3 C18 column with detection at 285 nm and a column temperature of 30°C.
- Validated the method according to International Council for Harmonisation (ICH) and United States Pharmacopeia (USP) guidelines.
Main Results:
- The optimized RP-HPLC method demonstrated high accuracy (92-111%), excellent precision (≤1.0% RSD), and strong linearity (R² > 0.999).
- The Box-Behnken design effectively enhanced method performance, robustness, and dependability.
- The method proved to be stability-indicating, capable of detecting and quantifying nitrofurantoin degradation products and impurities.
Conclusions:
- The developed Box-Behnken design-based RP-HPLC method is a reliable and validated stability-indicating approach for analyzing nitrofurantoin capsule formulations.
- This method is suitable for routine quality control, ensuring product safety and regulatory compliance.
- The systematic optimization approach enhances confidence in the analytical results for nitrofurantoin impurities.
More Related Videos
09:24Application and Methodology of the Non-destructive 19F Time-domain NMR Technique to Measure the Content in Fluorine-containing Drug Products
Published on: August 22, 2017
07:38A General Method for Detecting Nitrosamide Formation in the In Vitro Metabolism of Nitrosamines by Cytochrome P450s
Published on: September 25, 2017
Related Concept Videos
Amines to Sulfonamides: The Hinsberg Test
Generally, a primary amine reacts with the Hinsberg reagent to produce an N-substituted benzenesulfonamide. The electron-withdrawing sulfonyl...
Clinically Relevant Drug Product Specifications: Methods of Establishment